%0
Generic
%T
Brigatinib (BRG) in crizotinib (CRZ)-refractory ALK+ non–small cell lung cancer (NSCLC): Efficacy updates and exploratory analysis of CNS ORR and overall ORR by baseline (BL) brain lesion status.
%A Huber, Rudolf M.
%A Kim, Dong-Wan
%A Ahn, Myung-Ju
%A Langer, Corey J.
%A Tiseo, Marcello
%A West, Howard
%A Groen, Harry J.M.
%A Reckamp, Karen L.
%A Hochmair, Maximilian J.
%A Leighl, Natasha B.
%A Holmskov Hansen, Karin
%A Gettinger, Scott N.
%A Paz-Ares, Luis G.
%A Kim, Edward S.
%A Smit, Egbert F.
%A Kim, Sang-We
%A Reichmann, William
%A Kerstein, David
%A Camidge, D. Ross
%I American Society of Clinical Oncology (ASCO)
%@ 0732-183X
%@ 1527-7755
%K Cancer Research
%K Oncology
%D 2018
%C American Society of Clinical Oncology (ASCO)
%U http://slubdd.de/katalog?TN_libero_mab2